Results 1 - 7 of 7
1
[PROJECT] STEMAPL - APL a model for oncogene-targeted leukemia cure
ID: 268729
Start date: 2011-07-01, End date: 2017-06-30
Acute promyelocytic leukaemia, APL, is probably one of the best-understood malignancies and the only one where highly efficient oncogene-targeted therapies (retinoic acid and arsenic) actually cure the disease. Our recent studies have addressed the molecular basis for transfo...
Programme: FP7-IDEAS-ERC
Record Number: 99545
Last updated on: 2017-05-29
[PROJECT] COHEMI - Coordinating resources to assess and improve health status of migrants from Latin America
ID: 261495
Start date: 2011-01-01, End date: 2013-12-31
European health systems are committed to meeting the challenge of understanding the needs of migrant populations and adapting their services to meet these needs. The difficulties inextricably linked to this challenge are caused by the complexity of migration patterns and the ...
Programme: FP7-HEALTH
Record Number: 97668
Last updated on: 2017-05-26
[PROJECT] E PIAF - Enhanced Protective Immunity Against Filariasis
ID: 242131
Start date: 2010-03-01, End date: 2014-08-31
Filarial infections remain a major public health problem in West and Central Africa. Three filarial species are involved: Onchocerca volvulus (onchocerciasis or river blindness); Wuchereria bancrofti (lymphatic filariasis); and Loa loa (the eye worm). Treatment of onchocercia...
Programme: FP7-HEALTH
Record Number: 94066
Last updated on: 2017-05-25
[PROJECT] AFRICA BUILD - AFRICA BUILD (Building a Research and Education Infrastructure for Africa)
ID: 266474
Start date: 2011-08-01, End date: 2014-07-31
Topic: AFRICA BUILD aims to improve capacity for health research and education in Africa, through Information Technologies (IT). It will provide innovative learning and research opportunities. Background: The EU has supported many IT and health initiatives, with significant r...
Programme: FP7-HEALTH
Record Number: 99621
Last updated on: 2017-05-26
ID: 223341
Start date: 2009-01-01, End date: 2012-06-30
The global aim of RAPSODI is : · to develop a human vaccine candidate against most or all Leishmania species that cause the most severe leishmaniasis in the world. An unique vaccinal solution will thus be provided to protect against the various clinical phenotypes (namely vis...
Programme: FP7-HEALTH
Record Number: 89346
Last updated on: 2017-05-25
[PROJECT] LEISHEPINETSA - Control strategies for visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL) in South America: applications of molecular epidemiology.
ID: 15407
Start date: 2006-01-01, End date: 2009-09-30
A full and detailed understanding of the transmission cycles and epidemiology of visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL) is necessary to develop disease control and surveillance. Molecular epidemiology and population genetics can resolve the diversity...
Programme: FP6-INCO
Record Number: 78459
Last updated on: 2008-07-08
[PROJECT] SCOOTT - Sustainable control of Onchocerciasis today and tomorrow
ID: 32321
Start date: 2006-11-01, End date: 2010-10-31
The purpose of this project is to improve sustainable control of onchocerciasis (river blindness) through refinement of existing chemotherapeutic regimes and identification of new targets and approaches for integrated control that will combine chemotherapy with vaccination.
%...
Programme: FP6-INCO
Record Number: 81329
Last updated on: 2011-01-24
1
List retrieved on: 2017-08-02
